| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:28:45 UTC |
|---|
| Update Date | 2021-09-26 22:55:33 UTC |
|---|
| HMDB ID | HMDB0246460 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- |
|---|
| Description | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-, also known as 4-hydroxyniridazole, belongs to the class of organic compounds known as nitrothiazoles. Nitrothiazoles are compounds containing a thiazole ring which bears a nitro group. Based on a literature review very few articles have been published on 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | OC1CN(C(=O)N1)C1=NC=C(S1)[N+]([O-])=O InChI=1S/C6H6N4O4S/c11-3-2-9(5(12)8-3)6-7-1-4(15-6)10(13)14/h1,3,11H,2H2,(H,8,12) |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Hydroxyniridazole | HMDB |
|
|---|
| Chemical Formula | C6H6N4O4S |
|---|
| Average Molecular Weight | 230.2 |
|---|
| Monoisotopic Molecular Weight | 230.010975863 |
|---|
| IUPAC Name | 4-hydroxy-1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one |
|---|
| Traditional Name | 4-hydroxy-1-(5-nitro-1,3-thiazol-2-yl)imidazolidin-2-one |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC1CN(C(=O)N1)C1=NC=C(S1)[N+]([O-])=O |
|---|
| InChI Identifier | InChI=1S/C6H6N4O4S/c11-3-2-9(5(12)8-3)6-7-1-4(15-6)10(13)14/h1,3,11H,2H2,(H,8,12) |
|---|
| InChI Key | NMJKHHQCDHSEIJ-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as nitrothiazoles. Nitrothiazoles are compounds containing a thiazole ring which bears a nitro group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Azoles |
|---|
| Sub Class | Thiazoles |
|---|
| Direct Parent | Nitrothiazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Nitroaromatic compound
- Nitrothiazole
- 2,5-disubstituted 1,3-thiazole
- Imidazolidinone
- Heteroaromatic compound
- Imidazolidine
- Organic nitro compound
- Urea
- Carbonic acid derivative
- C-nitro compound
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Allyl-type 1,3-dipolar organic compound
- Organic oxoazanium
- Alkanolamine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organic zwitterion
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 10.3175 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.53 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 447.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 348.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 49.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 212.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 78.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 321.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 246.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 978.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 656.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 48.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 708.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 215.6 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 300.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 741.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 633.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 432.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TMS,isomer #1 | C[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C | 2350.4 | Semi standard non polar | 33892256 | | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TMS,isomer #1 | C[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C | 2267.2 | Standard non polar | 33892256 | | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TMS,isomer #1 | C[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C | 3077.8 | Standard polar | 33892256 | | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C(C)(C)C | 2795.5 | Semi standard non polar | 33892256 | | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C(C)(C)C | 2771.0 | Standard non polar | 33892256 | | 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)-,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC1CN(C2=NC=C([N+](=O)[O-])S2)C(=O)N1[Si](C)(C)C(C)(C)C | 3101.7 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (Non-derivatized) - 70eV, Positive | splash10-052f-9830000000-9650ab32a7a5e6294a68 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 2-Imidazolidinone, 4-hydroxy-1-(5-nitro-2-thiazolyl)- GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-03 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-13 | Wishart Lab | View Spectrum |
|
|---|